Navigation Links
First Pharmaceutical Company Comes to Hoboken, NJ: Swiss-Based Octapharma to Move U.S. Headquarters to SJP Properties Waterfront Corporate Center II

Dino Mattessich Brokers 15,204 Square Foot Lease at Class-A Office Tower

HOBOKEN, N.J., Jan. 30 /PRNewswire/ -- SJP Properties, one of the largest development companies in the New York metropolitan area, has announced that Swiss-based Octapharma will relocate its U.S. headquarters to Waterfront Corporate Center II, one of the most coveted office campus locations in the Northeast. Octapharma, an independent, global plasma fraction specialist, will move its U.S. marketing and sales operations from Virginia to the River Street office tower, which sits on the edge of the Hudson River.

Dino M. Mattessich, who recently joined Jones Lang LaSalle's Parsippany office as a vice president, brokered the 15,204 square foot lease.

"SJP Properties takes pride in meeting the facilities needs for many of the world's premier corporations," said Steven M. Pozycki, senior vice president of Parsippany-based SJP Properties. "We're very pleased to have attracted the first pharmaceutical company to the City of Hoboken. New Jersey has emerged as the national center of the pharmaceutical business sector so we are confident Hoboken will become increasingly attractive to this industry. We are equally proud that Waterfront Corporate Center has become a leading destination for many of the world's premier corporations."

The Waterfront Corporate Center is a joint venture between SJP Properties, Prudential Insurance Company of America, the Port Authority of New York and New Jersey, and the City of Hoboken. Once fully-built, the campus will include nearly 1.5 million square feet of Class-A commercial and retail space with spectacular unobstructed views of the New York City skyline and the Hudson River.

"We're very excited about bringing the first pharmaceutical company headquarters to Hoboken," said Mattessich. "The city is truly experiencing a renaissance, not just in office development, but also retail and residential projects creating a vibrant 24/7 city. Congratulations to SJP Properties on securing this prestigious tenant and for their leadership in the transformation of Hoboken into a primary choice for office tenants."

Waterfront Corporate Center offers the last available commercial office high-rises in Hoboken, located directly on the Hudson River, just steps from train, ferry and bus service to New York City and major points throughout New Jersey.

"There is no better location for Octapharma's United States headquarters than at the Waterfront Corporate Center," said Flemming Nielsen, General Manager of Octapharma USA. "We see our staffing needs tripling over the next year, and this building gives us the room to expand. The New York and New Jersey area also provides the talent pool we need to remain at the forefront of our industry."

The company will move to Hoboken in mid-February. The European-inspired design concept behind the new executive offices of Octapharma was to create an open and modern space reflective of their European culture and corporate brand. The layout reflects perimeter offices with full height glass facades allowing the interior spaces to enjoy both the natural daylight and breathtaking views of Manhattan.

"Waterfront Corporate Center II was one of the few properties capable of fitting the complex needs of our company," said Nielsen. "The building is stunning and the location is strategically ideal for our business."

Waterfront Corporate Center I and Waterfront Corporate Center II together comprise 943,000 square feet of world-class office space and ground level retail and amenities, including a state-of-the-art fitness facility, PNC bank branch, Chock Full of Nuts Caf, Jos. A. Bank Clothiers Inc. and Melting Pot. The campus is already home to such distinguished tenants as Marsh & McLennan, John Wiley & Sons' Global Headquarters, Sumitomo Trust and Banking, and Mizuho Securities among other prestigious corporations.

The third and final commercial office building on the campus, and the Hoboken waterfront, will be Waterfront Corporate Center III, a 520,000 square foot, 14-story, Class-A office tower. SJP Properties announced in November that Waterfront Corporate Center III will seek Leadership in Energy and Environmental Design (LEED) Silver certification from the U.S. Green Building Council, making the building one of the largest LEED-certified commercial developments in New Jersey.

With SJP Properties commitment to also build its flagship 11 Times Square as a LEED Gold certified tower, the company has launched one of the largest environmentally responsible commercial development initiatives in the Northeast. The 40-story, 1.1 million square foot Manhattan office tower is the largest speculative commercial development under construction in New York City and will be delivered to the market for tenant occupancy in late 2009.

About SJP Properties

For more than 25 years, SJP Properties has been setting the benchmark for excellence in speculative, build-to-suit, investment and development services of Class-A office space in the New York Metropolitan area serving major multinational and national tenants. Throughout its history, the company has developed in excess of 20 million square feet of headquarters-quality, Class-A office space and currently has an additional 6 million square feet in its development pipeline. SJP Properties is headquartered in Parsippany, New Jersey. SJP Properties is presently developing over $1.5 billion of commercial and residential properties in the New York metropolitan area, including 11 Times Square, a 1.1 million-square-foot commercial and retail tower that will be delivered to the market in 2009. For more information on SJP Properties, please call (973) 299-9117 or visit

About Jones Lang LaSalle

Jones Lang LaSalle (NYSE: JLL), the only real estate money management and services firm named to FORTUNE magazine's "100 Best Companies to Work For" and Forbes magazine's "400 Best Big Companies," has approximately 160 offices worldwide and operates in more than 450 cities in over 50 countries. With 2006 revenue of more than $2.0 billion, the company provides comprehensive integrated real estate and investment management expertise on a local, regional and global level to owner, occupier and investor clients. Jones Lang LaSalle is an industry leader in property and corporate facility management services, with a portfolio of approximately 1.3 billion square feet worldwide. In 2006, the firm completed capital markets sales and acquisitions, debt financing, and equity placements on assets and portfolios valued at $70.9 billion. LaSalle Investment Management, the company's investment management business, is one of the world's largest and most diverse real estate money management firms, with approximately $46.9 billion of assets under management. For further information, please visit our Web site,

About Octapharma

Octapharma, a Swiss-based company, is an independent, global plasma fractionation specialist. Its core business is the development, production and sale of high quality plasma derivatives. From its foundation in 1983 the company has grown to employ over 1800 people in 27 countries, including the United States. Octapharma first opened offices in Virginia in 2004 before relocating to Hoboken, N.J. in 2008.

For more information, please visit

SOURCE Octapharma
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you ... for not only fulfilling the needs of advisers and clients but going above ... and providing top-tier customer service. However, there's always room for improvement, which is ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... largest, most successful and prominent nonprofit healthcare organizations in the country. They have ... with various organizations, and helped advance the healthcare industry as a whole through ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term Support) ... supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk ...
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... ... 26, 2015 , ... Jobs in hospital medical laboratories and in the imaging ... staffing agency Aureus Medical Group . These fields, as well as ... searching for healthcare jobs through the company’s website, , The leading ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... --> --> ... The potential to save costs, improve treatment quality and ... fully exploited as yet. Here, particular emphasis is placed ... mobile tablet or directly at the patients, bedside. ... ) -->      (Photo: ...
(Date:11/27/2015)... , Nov. 26, 2015 ... addition of the "2016 Global Tumor ... Country Volume and Sales Segment Forecasts, Innovative ... report to their offering. --> ... of the "2016 Global Tumor Marker ...
(Date:11/26/2015)... November 26, 2015 --> ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... has found that immunotherapy can be efficiently combined with ...
Breaking Medicine Technology: